Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1714456

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1714456

Europe Protein Sequencing Market By Product & Service, By Application, By End User, By Country, Competition, Forecast and Opportunities, 2020-2030F

PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4000
PDF and Excel (Multi-User License)
USD 5000
PDF and Excel (Custom Research License)
USD 7500

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Europe Protein Sequencing Market was valued at USD 469.36 Million in 2024 and is expected to grow at a CAGR of 4.92% to reach USD 627.03 Million by 2030. The market is gaining momentum due to the expanding application of proteomics in pharmaceutical and biotechnology research. With rising interest in precision medicine, protein sequencing is playing a critical role in decoding disease mechanisms at the molecular level. It is widely used in identifying and validating biomarkers, facilitating the development of targeted therapies. The increasing prevalence of chronic and complex diseases is pushing pharmaceutical firms to adopt advanced sequencing techniques for streamlined drug discovery and development. Furthermore, the integration of protein sequencing into personalized medicine is advancing diagnostics and tailored treatment approaches, reinforcing its significance in healthcare and life sciences.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 469.36 Million
Market Size 2030USD 627.03 Million
CAGR 2025-20304.92%
Fastest Growing SegmentGenetic Engineering
Largest MarketGermany

Key Market Drivers

Surging Demand for Precision Medicine and Biomarker Discovery

The growing demand for precision medicine and biomarker identification is a key factor propelling the Europe Protein Sequencing Market. Precision medicine focuses on tailoring treatment to individual patients based on genetic and molecular profiles, making protein sequencing essential for identifying disease-specific biomarkers. Through detailed analysis of protein structures and functions, sequencing enables the discovery of biomarkers for early diagnosis, monitoring, and targeted therapy-especially for diseases like cancer, cardiovascular disorders, and neurological conditions. The identification of precise biomarkers supports the development of more effective, lower-risk therapies. As a result, significant investments are being made in high-resolution and reproducible sequencing technologies, underscoring protein sequencing's expanding role in both research and clinical applications.

Key Market Challenges

High Cost of Equipment and Consumables

The high cost of equipment and consumables is a major barrier in the Europe Protein Sequencing Market. Technologies such as mass spectrometry and next-generation sequencing require significant capital investment. The equipment needed for high-throughput protein sequencing is expensive to purchase and maintain, involving costs for servicing, software updates, and skilled personnel. Additionally, consumables like reagents and sequencing chips contribute to recurring expenses, raising the overall cost of experimentation. These financial burdens are especially limiting for small labs and academic institutions with budget constraints, thus hindering broader market adoption and restricting access to protein sequencing technologies.

Key Market Trends

Integration of AI and Machine Learning in Protein Analysis

The integration of artificial intelligence (AI) and machine learning (ML) in protein analysis is an emerging trend driving innovation in the Europe Protein Sequencing Market. AI and ML tools are transforming the way protein data is analyzed, enabling rapid and accurate processing of the vast datasets generated by sequencing technologies. These advanced algorithms improve protein identification, structural prediction, and functional analysis, supporting critical areas such as drug development, disease modeling, and biomarker discovery. By automating data interpretation and identifying complex patterns, AI and ML make protein research more efficient and scalable. They also enhance the precision of predictive models used in personalized medicine and therapeutic targeting, positioning AI-driven sequencing as a cornerstone of next-generation proteomics.

Key Market Players

  • Thermo Fisher Scientific
  • SCIEX Europe
  • Biognosys AG
  • Evotec SE
  • Sartorius AG
  • Proteome Sciences plc
  • Biotage AB
  • Eurofins Genomics Europe
  • Toplab GmbH
  • Mass Analytica S.L.

Report Scope:

In this report, the Europe Protein Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Europe Protein Sequencing Market, By Product & Service:

  • Protein Sequencing Products
  • Reagents & Consumables
  • Instruments
  • Software
  • Protein Sequencing Services

Europe Protein Sequencing Market, By Application:

  • Bio-therapeutics
  • Genetic Engineering
  • Others

Europe Protein Sequencing Market, By End User:

  • Academic Institutes & Research Centers
  • Pharmaceutical & Biotechnology Companies
  • Others

Europe Protein Sequencing Market, By Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Poland
  • Bulgaria
  • Finland
  • Portugal

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Europe Protein Sequencing Market.

Available Customizations:

Europe Protein Sequencing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 28481

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Europe Protein Sequencing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Service (Protein Sequencing Products {Reagents & Consumables, Instruments, Software}, Protein Sequencing Services)
    • 5.2.2. By Application (Bio-therapeutics, Genetic Engineering, Others)
    • 5.2.3. By End User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others)
    • 5.2.4. By Country
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. Germany Protein Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service
    • 6.2.2. By Application
    • 6.2.3. By End User

7. France Protein Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Service
    • 7.2.2. By Application
    • 7.2.3. By End User

8. United Kingdom Protein Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Service
    • 8.2.2. By Application
    • 8.2.3. By End User

9. Italy Protein Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Service
    • 9.2.2. By Application
    • 9.2.3. By End User

10. Spain Protein Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Service
    • 10.2.2. By Application
    • 10.2.3. By End User

11. Russia Protein Sequencing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product & Service
    • 11.2.2. By Application
    • 11.2.3. By End User

12. Poland Protein Sequencing Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product & Service
    • 12.2.2. By Application
    • 12.2.3. By End User

13. Bulgaria Protein Sequencing Market Outlook

  • 13.1. Market Size & Forecast
    • 13.1.1. By Value
  • 13.2. Market Share & Forecast
    • 13.2.1. By Product & Service
    • 13.2.2. By Application
    • 13.2.3. By End User

14. Finland Protein Sequencing Market Outlook

  • 14.1. Market Size & Forecast
    • 14.1.1. By Value
  • 14.2. Market Share & Forecast
    • 14.2.1. By Product & Service
    • 14.2.2. By Application
    • 14.2.3. By End User

15. Portugal Protein Sequencing Market Outlook

  • 15.1. Market Size & Forecast
    • 15.1.1. By Value
  • 15.2. Market Share & Forecast
    • 15.2.1. By Product & Service
    • 15.2.2. By Application
    • 15.2.3. By End User

16. Market Dynamics

  • 16.1. Drivers
  • 16.2. Challenges

17. Market Trends & Developments

  • 17.1. Merger & Acquisition (If Any)
  • 17.2. Product Launches (If Any)
  • 17.3. Recent Developments

18. Europe Protein Sequencing Market: SWOT Analysis

19. Porters Five Forces Analysis

  • 19.1. Competition in the Industry
  • 19.2. Potential of New Entrants
  • 19.3. Power of Suppliers
  • 19.4. Power of Customers
  • 19.5. Threat of Substitute Products

20. Competitive Landscape

  • 20.1. Thermo Fisher Scientific
    • 20.1.1. Business Overview
    • 20.1.2. Company Snapshot
    • 20.1.3. Products & Services
    • 20.1.4. Financials (As Reported)
    • 20.1.5. Recent Developments
    • 20.1.6. Key Personnel Details
    • 20.1.7. SWOT Analysis
  • 20.2. SCIEX Europe
  • 20.3. Biognosys AG
  • 20.4. Evotec SE
  • 20.5. Sartorius AG
  • 20.6. Proteome Sciences plc
  • 20.7. Biotage AB
  • 20.8. Eurofins Genomics Europe
  • 20.9. Toplab GmbH
  • 20.10. Mass Analytica S.L.

21. Strategic Recommendations

22. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!